Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Government Help For Life Sciences Sector Is Welcomed, But Still Not Enough

This article was originally published in The Pink Sheet Daily

Executive Summary

Therapeutic "clusters" are the next big idea, but unlikely to overshadow industry-academia tie-ups.

You may also be interested in...



Pharma and Academia: Finding New Ways to Join Hands for Mutual Benefit

As Big Pharmas seek to hedge their development risk and look for more externally sourced programs, partnerships with academic institutions are one of the many ingredients in the R&D secret sauce. Such deals aren't the academic-industry tie-ups of yore-where Big Pharma sought small money partnerships without giving a lot back to their academic partners. Business development execs view them as yet another way to access critically important innovation.

UK Life Sciences Package Includes "Innovation Pass" To Skirt NICE

LONDON - The UK 's Life Sciences Blueprint is an urgent bid to kick-start a sector that's increasingly important to the nation's future growth - especially in the light of the downturn in financial services

GSK Partners Leftover Assets With Academia

GlaxoSmithKline's Academic Drug Performance Unit isn't focused on what one might expect -trawling academic institutions for promising science and compounds to eventually bring into the fold

Related Content

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel